Propel Bio Management, Llc
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$158.7M
Q ending 2026-03-31
Prior quarter
$117.1M
Q ending 2025-12-31
Change
+35.5% QoQ · +84.3% YoY
Positions
38
reported holdings
Largest positions
All 38 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Plains Gp Hldgs L P | PAGP | Shares | $30.2M | 1.3M |
| Achieve Life Sciences Inc | ACHV | Shares | $11.4M | 3.8M |
| Phathom Pharmaceuticals Inc | PHAT | Shares | $9.4M | 841K |
| Delcath Sys Inc | DCTH | Shares | $9.2M | 980K |
| Corcept Therapeutics Inc | CORT | Shares | $6.0M | 148K |
| Abeona Therapeutics Inc | ABEO | Shares | $6.0M | 1.3M |
| Vor Biopharma Inc | VOR | Shares | $5.6M | 315K |
| Kyverna Therapeutics Inc | KYTX | Shares | $5.6M | 644K |
| Milestone Pharmaceuticals In | MIST | Shares | $5.1M | 4.1M |
| Celldex Therapeutics Inc New | CLDX | Shares | $4.1M | 131K |
| Compass Pathways Plc | CMPS | Shares | $4.1M | 742K |
| Viridian Therapeutics Inc | VRDN | Shares | $4.1M | 210K |
| Inventiva Sa | IVA | Shares | $4.0M | 725K |
| Sab Biotherapeutics Inc | SABS | Shares | $3.9M | 1.0M |
| Orchestra Biomed Hldgs Inc | OBIO | Shares | $3.8M | 897K |
| 4D Molecular Therapeutics In | FDMT | Shares | $3.6M | 380K |
| Oculis Holding Ag | Shares | $3.3M | 122K | |
| Ocular Therapeutix Inc | OCUL | Shares | $3.2M | 382K |
| Upstream Bio Inc | UPB | Shares | $3.1M | 342K |
| Aquestive Therapeutics Inc | AQST | Shares | $3.0M | 711K |
| Eyepoint Inc | EYPT | Shares | $2.8M | 216K |
| Trevi Therapeutics Inc | TRVI | Shares | $2.6M | 224K |
| Zevra Therapeutics Inc | ZVRA | Shares | $2.6M | 282K |
| Immunic Inc | VTLUSD | Shares | $2.6M | 2.3M |
| Coherus Oncology Inc | CHRS | Shares | $2.4M | 1.4M |
| Ovid Therapeutics Inc | OVID | Shares | $2.0M | 921K |
| Palisade Bio Inc | PALI | Shares | $2.0M | 1.1M |
| Kalaris Therapeutics Inc | KLRS | Shares | $1.7M | 296K |
| Uniqure Nv | Shares | $1.7M | 105K | |
| Leonabio Inc | LONA | Shares | $1.5M | 149K |
| Nuvation Bio Inc | NUVB | Shares | $1.4M | 329K |
| Maze Therapeutics Inc | MAZE | Shares | $1.3M | 44K |
| Evommune Inc | EVMN | Shares | $1.3M | 56K |
| Corvus Pharmaceuticals Inc | CRVS | Shares | $1.3M | 86K |
| Aldeyra Therapeutics Inc | ALDX | Shares | $1.2M | 731K |
| Artiva Biotherapeutics Inc | ARTV | Shares | $950K | 146K |
| Connect Biopharma Hldgs Ltd | Shares | $554K | 209K | |
| Satellos Bioscience Inc | MSLE | Shares | $57K | 10K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.